eTerapija APK - v1.1

20+ votes, 4.85/5

... [readmore]


⇣ Download APK ()

This is an original APK file direct fetch from google play. It is safe to download and free of any virus.

Version 1.1
Update
Size
Category Medical
Developer Novartis Pharma AG
Downloads ↓ 0
⇣ Download on Google play ()

This is an original APK file direct fetch from google play. It is safe to download and free of any virus.

Basic Infos

License type Free
Version 1.1
Size
Requirement 4.1 and up
Type app
Category Medical
Package name: com.novartis.sandoz.hr.eterapija.ext
Slogan:

Screenshots (8 images)

eTerapija screenshot 1 eTerapija screenshot 2 eTerapija screenshot 3 eTerapija screenshot 4 eTerapija screenshot 5 eTerapija screenshot 6 eTerapija screenshot 7 eTerapija screenshot 8

About eTerapija APK

eTerapija poster
eTerapija APK version 1.1 poster

Latest update


Sve je puno brže nego u prošloj verziji. Aplikacija je stabilnija i bugovi iz prošle verzije su popravljeni.

eTerapija APK Description


This is an app which reminds patients when do they have to take their drugs and shows them what is the required dosage and how does the drug look like.
It also provides measurements diary which allows patients to keep track of their measurements in one place.

How to install eTerapija APK for Android


Download eTerapija APK file from APKPure.live, then follow these steps:

Update Phone Settings

  • Go to your phone Settings page
  • Tap Security or Applications (varies with device)
  • Check the Unknown Sources box
  • Confirm with OK

Go to Downloads

  • Open Downloads on your device by going to My Files or Files
  • Tap Install when prompted, the APK file you downloaded will be installed on your device.

How to install eTerapija APK on Windows PC 7/8/10/11 or MAC?


Download eTerapija APK file from APKPure.live to your PC (ex: C://Users/xxx/Downloads/, then follow these steps appear on screen.

Using Emulator:

  • Download And Install one Emulator Softwares (Ex: Bluestacks, GenyMotion, NoxPlayer)

Similar applications


New Apps



Comments

No comment Yet.